A group of New Jersey home health care companies (collectively, the BAYADA Companies), have agreed to pay $17 million to resolve claims that they violated the False Claims Act and Anti-Kickback Statute.
In November 2020, California voters passed a ballot initiative, Proposition 22, by an overwhelming majority. Proposition 22 exempts certain app-based drivers from the requirements of California’s Assembly Bill 5 (AB 5) by deeming them independent contractors, rather than employees.
John Peter Smith Hospital (JPS) agreed to pay more than $3.3 million to settle allegations that it violated the False Claims Act by upcoding hundreds of claims submitted to federal healthcare programs.
The Pharmaceutical Research and Manufacturers of America (PhRMA) – a leading lobbying and advocacy group for drug manufacturers – has released an updated version of its “Code on Interactions with Health Care Professionals” (the PhRMA Code or the Code).
On August 16, 2021, former New York Governor Andrew Cuomo announced that all healthcare workers in New York State are required to be vaccinated against COVID-19. The mandate is applicable to staff at hospitals and long-term care facilities such as nursing homes, adult care facilities, and other cong
In December 2020, the Council of the District of Columbia passed the Ban on Non-Compete Agreements Amendment Act of 2020.
The Middle District of Pennsylvania recently rejected arguments that a report created in response to a data breach was protected as work-product and/or under attorney-client privilege because:
A Florida owner of telemedicine companies is charged with orchestrating a health care fraud and illegal kickback scheme that involved the submission of over $784 million in false Medicare claims.
JD Supra has awarded our Investigations team with its 2021 Readers' Choice Award as the Top Firm for White Collar analysis. The award comes during a year when the legal intelligence platform quadrupled its content production.
The sharp increase in deal volume and consumer demand, coupled with an uncertain regulatory future and the lack of a developed market framework for dealmaking all combine to create a potent risk/reward cocktail for brands and sports teams looking to launch NFT programs.
Hospitals have long used color-coded wristbands as a patient safety initiative. Recently, the FDA issued a letter to medical device manufacturers to caution them against using colors for device identification wristbands that could create confusion for clinicians and result in inappropriate medical
Headlines that Matter for Privacy and Data Security
Fashion House Sues Kendall Jenner for Failing to Appear at a Photoshoot During the COVID-19 Pandemic
On August 2, 2021, the Italian fashion brand Liu Jo filed a lawsuit in the Southern District of New York against model Kendall Jenner for $1.8 million, alleging that Jenner breached the terms of her modeling agreement by failing to reschedule a photoshoot that was postponed due to COVID-19 travel re
On August 10, 2021, the Senate passed a bipartisan infrastructure bill that included many pieces of President Biden’s plan, but also contained numerous revisions, reflective of the compromises necessary to pass this ambitious legislation in the Senate.
On August 11, 2021, Sheng-Wen Cheng was sentenced to 72 months in prison for his alleged participation in multiple schemes related to Covid-19 pandemic loan fraud and securities fraud.
In Natarajan v. Dignity Health, the Supreme Court rejected a physician’s challenge to a peer review hearing officer based on alleged financial bias. In doing so, the Court gave hospitals helpful and long-needed guidance regarding such challenges
Non-fungible tokens have attracted widespread attention this year due to high-profile auctions involving NFTs representing digital artwork. Just as NFTs have invigorated the digital art landscape, they can rejuvenate patent monetization – making it easier, more secure, and accessible.
A federal district court recently found that a large diet and wellness company likely violated California’s Automatic Renewal Law by failing to send consumers confirmation emails that included specific instructions about how to cancel their subscription memberships.
The FDA’s position that the Food, Drug, and Cosmetic Act (FDCA) prohibits CBD from being sold in interstate commerce as a dietary supplement or food ingredient makes national companies hesitant to sell products containing CBD or do business with the CBD industry.
CMS has released a proposed rule (the Proposed Rule) which, if finalized and adopted, would rescind the Trump Administration’s attempt to align reimbursement under Medicare Part B for certain drugs with benchmark pricing obtained from surveys of other countries.
On July 26, 2021, a bipartisan group of senators, led by Sen. Charles E. Grassley (R-Iowa), introduced the False Claims Amendments Act of 2021, a bill that would amend the False Claims Act (FCA) in several ways.
The majority of states in the US have either decriminalized cannabis or enacted laws authorizing its uThe majority of states in the US have either decriminalized cannabis or enacted laws authorizing its use for medical or non-medical se for medical or non-medical (aka “recreational” or “adult”) use.
Consumer Financial Services Partner Jenny Lee recently spoke with American Banker reporter Kate Berry about key enforcement issues surrounding the newly led Consumer Financial Protection Bureau.
By September 30, all hospital workers—including physicians—must be vaccinated.